Back to results
US 8,404,681 B2Granted
Xanthones, thioxanthones and acridinones as DNA-PK inhibitors
AssigneeLuitpold Pharmaceuticals, Inc.
InventorsJames W. Halbrook, Edward A. Kesicki, Laurence E. Burgess, Stephen T. Schlachter, Charles T. Eary, Justin G. Schiro
Life of this patent
Estimating the term…
Abstract
Compound that inhibit DNA-dependent protein kinase, compositions comprising the compounds, methods of inhibiting the DNA-PK biological activity, methods of sensitizing cells the agents that cause DNA lesions, and methods of potentiating cancer treatment are disclosed.
Claims18
A compound having a formula
- or a pharmaceutically acceptable salt thereof,
- wherein m is an integer 0 through 3;
- X is O, S(O)0-2, or NRa;
- Z, independently, is CRb or N;
- R1, independently, is selected from the group consisting of halo, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, N(Rd)2, ORd, carboxy, wherein the carboxy is not carboxyl, nitro, OC1-3alkyleneN(Rd)2, N(Rd)—C1-3alkyleneN(Rd)2, OC1-3alkyleneC(═O)ORd, O(C1-3alkylene) OP(═O)(ORd)2, O(C1-3alkylene)OP(═O)(ONa)2, OP(═O)—(ORd)2, OP(═O)(ONa)2, cyano, aldehyde, carboxamide, thiocarboxamide, acyl, mercapto, sulfonyl, trifluoromethyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl;
- or
- two R1 groups are taken together with the atoms to which each is attached to form a 5-, 6-, or 7-membered ring, wherein 1 or 2 carbon atoms of R1 optionally is a heteroatom selected from the group consisting of O, N, and S, said ring optionally substituted with one or more ═O, ═S, ═NH, ORd, N(Rd)2, carboxyl, carboxy, alkyl, aryl, substituted aryl, heteroaryl, or substituted hetercaryl, said heteroatom optionally substituted with a group selected from the group consisting of aryl, substituted aryl, alkyl, substituted alkyl, and acyl;
- Ra is selected from the group consisting of hydro, C1-4alkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, C1-3alkylenearyl, C1-3alkyleneheteroaryl, C1-3alkyleneheterocycloalkyl, C1-4alkylene-N(Rd)2, C1-4alkyleneORd, C1-4alkyleneC(═O)ORd, C(═O)Rd, C(═O)N(Rd)2, C(═O)ORd, C(═O)SRd, C(═S)N(Rd)2, SO2Rd, SO2N(Rd)2, C(═O)NRdC1-4alkyleneORd, C(═O)NRdC1-4alkyleneheterocycloalkyl, C(═O)C1-4alkylenearyl, C(═O)C1-4alkyleneheteroaryl, C1-4alkyleneC(═O)C1-4alkylenearyl, C1-4alkyleneC(═O)C1-4alkyleneheteroaryl, C1-4alkylene-C(═O) heterocycloalkyl, C1-4alkyleneNRdC(═O)Rd, C1-4 alkyleneOC1-4alkyleneORd, C1-4alkyleneOC1-4alkyleneC(═O)ORd, and C1-4alkyleneC(═O)N(Rd)2;
- Rb, independently, is selected from the group consisting of hydro, alkyl, halo, aldehyde, ORd, O(C1-3alkylene)OP(═O)(ORd)2, O(C1-3alkylene)OP(═O)(ONa)2, OP(═O)(ORd)2, OP(═O)(ONa)2, nitro, N(Rd)2, carboxyl, carboxy, sulfonamido, sulfamyl, and sulfo;
- and
- Rd, independently, is selected from the group consisting of hydro, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, aryl, C1-3alkylenearyl, substituted aryl, heteroaryl, and substituted heteroaryl.
8 more elements
Dependencies are inferred from the claim text.